SLC16A1 and hepatocellular carcinoma: AR-C155858, BAY-8002 and Londonamine (LND) also showed effective MCT1 inhibitory and immunomodulatory activities, and the cytotoxicity of some anti-tumor drugs (such as anti-PD-1) of HCC was increased after LND treatment (221–225).